Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats

rHuEPO plays a central role as chemicals for the treatment of many diseases. Due to its short half-life, the main aim for this pharmacokinetic study is to investigate a newly developed PEG-rHuEPO with large molecular weight in SD rats. After a single intramuscular administration of different doses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xiaohan, Chen, Zhiyong, Yu, Zhuoran, Ge, Yonghong, Zeng, Xianyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913096/
https://www.ncbi.nlm.nih.gov/pubmed/24575314
http://dx.doi.org/10.1155/2014/918686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913096/
https://www.ncbi.nlm.nih.gov/pubmed/24575314
http://dx.doi.org/10.1155/2014/918686

Ejemplares similares